News

Join our team

Want to be part of a small, vibrant team working to make a real difference to the lives of people affected by AS? We have two exciting vacancies. Helpline & Volunteer Engagement Officer We are looking for someone to take on the dual role of  Working on the NASS Helpline to...


Presciption charges survey

NASS is a member of the Prescription Charges Coalition, which has launched a new survey looking at the ways in which prescription charges affect the lives of people in England with long-term conditions such as ankylosing spondylitis. At the moment, people in England with ankylosing spondylitis who work have...


NICE publishes Spondyloarthritis Guidelines

NASS has sucessfully campaigned for NICE to produce guidelines on spondyloarthritis Debbie Cook, Chief Executive at NASS has been a member of the Guideline Development Group working with NICE for over two years, particularly giving the patients’ perspective.  The Guideline was issued at the end of February 2017.  NASS will...


Zumbathon for NASS!

Join Stefania and her friends as they host a Zumbathon for NASS! Taking place on 8 April in Stoke Newington, London, the event is a 2 hour Zumba marathon for up to 200 people, with all the proceeds donated to NASS. The event will include a raffle, lots of...


Sent home with an unstable spinal fracture

Dr Linda Dykes, Consultant in Emergency Medicine has co-produced a blog with NASS Member Gareth Dwyer. It highlights the risk of unusual, spontaneous and dangerous fractures in AS that may occur with minimal or no trauma. The blog talks very honestly about Gareth's unsatisfactory visit to the Emergency Department,...


NASS Members' Day 2017

Join NASS for Members’ Day 2017 in Sheffield This year Members Day will be held on 17 June at Bramall Lane, Sheffield, the home of Sheffield United Football Club.  To book please complete the form at the bottom of this page and then visit the NASS shop to pay the...


What's your view on biosimilars?

Are you prescribed infliximab or etanercept? A PhD student in Pharmacy at Keele University is carrying out research into biosimilars.  He wants to know your opinions and experiences of biosimilars for AS. So, if you have AS and are currently prescribed either: Infliximab (Remicade, Remsima, Inflectra or Flixabi), or,  Etanercept...


Interested in becoming a NASS trustee?

NASS is keen that its Council of Management (our Board of Trustees) reflects the whole of the diverse group of people that we serve. As most people know, the average age of onset of AS is 24 and we would love to encourage someone from this younger age group to be...


And the 'You Changed My Life Award' goes to........

We launched our first ever Patients' Choice awards in 2016 to mark our 40th anniversary. You voted in your hundreds for the health professionals who have made the difference to you with your AS. Most of the awards were presented at our Parliamentary reception in Westminster in November 2016. But one...


NASS Research Fund returns for 2017

We are delighted to announce that the NASS Research Fund is back for 2017. We are calling on for applications to the fund which has been running since 2015, with funding awarded to 6 projects so far. Download an application form Download information for applicants The closing date for applications...

  • First
  • Previous
  • 1
  • 2
  • Next
  • Last

Give

Join

Shop